Doris Rubio

Prof. Doris Rubio


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Patient Education and Counseling
Verified
Journal Article
Closed access
CHCynthia L. Holland
Cynthia L. Holland
MNMichelle Abena Nkumsah
Michelle Abena Nkumsah
PMPenelope Morrison
Penelope Morrison
JTJill A. Tarr
Jill A. Tarr
DRDoris Rubio
Doris Rubio
JCJudy C. Chang
Judy C. Chang

14 September 2021 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
JDJamie Mihoko Doyle
Jamie Mihoko Doyle
NMNatalia E. Morone
Natalia E. Morone
CPChelsea N. Proulx
Chelsea N. Proulx
AAAndrew D. Althouse
Andrew D. Althouse
DRDoris Rubio
Doris Rubio
GWGretchen E. White
Gretchen E. White
Underrepresented minorities have higher attrition from the professoriate and have experienced greater negative impacts of the COVID-19 pandemic. The purpose of this study was to compare the impact of COVID-19 on the lives of 196 early-career physician-scientists versus PhD researchers who are underrepresented in biomedical research. Participants in the Building Up study answered questions on the impact of the COVID-19 pandemic on their personal and professional lives, and a mixed-methods approach was used to conduct the analysis. While most participants experienced increases in overall stress (72% of PhD researchers vs 76% of physician-scientists), physician-scientists reported that increased clinical demands, research delays, and the potential to expose family members to SARS-CoV-2 caused psychological distress, specifically. PhD researchers, more than physician-scientists, reported increased productivity (27% vs 9%), schedule flexibilities (49% vs 25%), and more quality time with friends and family (40% vs 24%). Future studies should consider assessing the effectiveness of programs addressing COVID-19-related challenges experienced by PhD researchers and physician-scientists, particularly those from underrepresented backgrounds.

24 May 2021 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
MNMarie Kamala Norman
Marie Kamala Norman
MHMegan E. Hamm
Megan E. Hamm
YSYael Schenker
Yael Schenker
CMColleen Mayowski
Colleen Mayowski
WHWilliam Hierholzer
William Hierholzer
SRSteven E. Reis
Steven E. Reis
Introduction: Human-centered design (HCD) training offers the potential to improve both team processes and products. However, the use of HCD to improve the quality of team science is a relatively recent application, and its benefits and challenges have not been rigorously evaluated. We conducted a qualitative study with health sciences researchers trained in HCD methods. We aimed to determine how researchers applied HCD methods and perceived the benefits and barriers to using HCD on research teams. Methods: We conducted 1-hour, semi-structured interviews with trainees from three training cohorts. Interviews focused on perceptions of the training, subsequent uses of HCD, barriers and facilitators, and perceptions of the utility of HCD to science teams. Data analysis was conducted using Braun and Clarke’s process for thematic analysis. Results: We interviewed nine faculty and nine staff trained in HCD methods and identified four themes encompassing HCD use, benefits, challenges, and tensions between HCD approaches and academic culture. Conclusions: Trainees found HCD relevant to research teams for stakeholder engagement, research design, project planning, meeting facilitation, and team management. They also described benefits of HCD in five distinct areas: creativity, egalitarianism, structure, efficiency, and visibility. Our data suggest that HCD has the potential to help researchers work more inclusively and collaboratively on interdisciplinary teams and generate more innovative and impactful science. The application of HCD methods is not without challenges; however, we believe these challenges can be overcome with institutional investment.

1 October 2007 in Journal of Palliative Medicine
Verified
Journal Article
Open access
ABAmber E. Barnato
Amber E. Barnato
JBJames E. Bost
James E. Bost
MFMaxwell H. Farrell
Maxwell H. Farrell
JLJudith R. Lave
Judith R. Lave
BABob Arnold
Bob Arnold
DADerek C. Angus
Derek C. Angus
Background : There are wide variations in hospital-level treatment intensity at the end of life that are not entirely explained by structural and market characteristics. Individual hospital microclimates must exist to perpetuate these practice variations. Objectives : To determine whether a closed-ended survey based upon staff perceptions of informal norms regarding life prolongation, palliation, collaborative decision-making, and patient–doctor familiarity can identify hospital microclimates and to assess whether these norms are related to variation in end-of-life treatment intensity. Design, participants, and measurements : Retrospective analysis of hospital discharge data at 11 purposively sampled Pennsylvania hospitals linked to a self-administered survey of 139 administrative and clinical staff fielded during site visits in 2004; measurements included year 2000 and 2004 rates of intensive care unit (ICU) admission, mechanical ventilation (MV), and hemodialysis among terminal hospitalizations at each hospital; survey respondent demographics, role, experience, and perceptions of their hospital's context and norms of end-of-life decision-making and treatment. Results : The purposively sampled hospitals exhibited wide variation in rates of ICU admission (38.2%–84.4%), MV (13.7%–41.4%), and hemodialysis (0%–9.2%) among terminal admissions. All 139 administered surveys were returned for a response rate of 100%. For each of 4 factors created from 19 survey items, staff responses varied more between hospitals than within hospitals ( p ≤ 0.03). One factor, patient–doctor familiarity, was inversely correlated with terminal ICU admission ( p < 0.001) and MV ( p = 0.03). Conclusions : Discrimination of differences in microclimates related to norms of treatment intensity at the end of life is feasible, but greater specificity of measurement will be required to explain objective measures of terminal admission treatment intensity.

PTPatricia Talbert
Patricia Talbert
George PerryGeorge Perry
George Perry
LRLuisel Ricks-Santi
Luisel Ricks-Santi
LLLourdes Soto de Laurido
Lourdes Soto de Laurido
Magda ShaheenMagda Shaheen
Magda Shaheen
DRDoris Rubio
Doris Rubio
Mentoring continues to be a salient conversation in academia among junior and senior faculty and administrators. Mentors provide guidance and structure to junior faculty so that they can meet their academic and professional goals. Mentors also convey skills in balancing life and academic pursuits. Therefore, the purpose of this descriptive study was to provide additional insight from a training program called Leading Emerging and Diverse Scientists to Success (LEADS) regarding successful strategies and challenges of mentoring relating to lessons learned from the scholars and mentees’ perspective. The LEADS program provided multiple training platforms to increase skills and knowledge regarding research to promote expertise in grant writing and submission for funding opportunities among diverse scientists. These findings reinforce the knowledge about the value of a mentor in helping define the research pathway of their mentee and underscoring the importance of mentoring.

28 December 2021 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
SSSusan S. Smyth
Susan S. Smyth
BCBarry Coller
Barry Coller
RJRebecca D. Jackson
Rebecca D. Jackson
PKPhilip A. Kern
Philip A. Kern
SMScott McIntosh
Scott McIntosh
ERErica Rosemond
Erica Rosemond
Introduction. Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical and Translational Science Awards (CTSA) offer KL2 programs to facilitate career development; however, the sustained impact has not been widely assessed. Methods: A survey comprised of quantitative and qualitative questions was sent to 2,144 individuals that had previously received support through CTSA KL2 mechanisms. The 547 responses were analyzed with identifying information redacted. Results: Respondents held MD (47%), PhD (36%), and MD/PhD (13%) degrees. After KL2 support was completed, physicians’ time was divided 50% to research and 30% to patient care, whereas PhD respondents devoted 70% time to research. Funded research effort averaged 60% for the cohort. Respondents were satisfied with their career progression. More than 95% thought their current job was meaningful. Two-thirds felt confident or very confident in their ability to sustain a career in clinical and translational research. Factors cited as contributing to career success included protected time, mentoring, and collaborations. Conclusion: This first large systematic survey of KL2 alumni provides valuable insight into the group’s perceptions of the program and outcome information. Former scholars are largely satisfied with their career choice and direction, national recognition of their expertise, and impact of their work. Importantly, they identified training activities that contributed to success. Our results and future analysis of the survey data should inform the framework for developing platforms to launch sustaining careers of translational scientists.